The effect of prazosin as a first-line therapy for the symptomatic benign prostatichypertrophy.
- Author:
Jong Jin LEE
1
;
Sung Joon HONG
Author Information
1. Department of Urology, Yonsei University, College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Benign prostatic hypertrophy;
Prazosin
- MeSH:
Humans;
Prazosin*;
Prostate;
Prostate-Specific Antigen;
Prostatic Hyperplasia;
Urinary Retention
- From:Korean Journal of Urology
1993;34(5):855-859
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We evaluated 41 patients with symptomatic benign prostatic hypertrophy who were treated with prazosin alone more than 3 months. Among them, 21 patients( 51.2%) showed improvement of both symptom score and maximal flow rate. There was the similar effectiveness on the patients with acute urinary retention as on the patients without retention. The pretreated prostate volume and prostate specific antigen were not statistically different between the responders and nonresponders.After with drawl of the medication, almost all patients immediately complained of the symptoms worsened again. So, we concluded that the d-blocker can be used as a first-line therapy in selected patients with symptomatic benign prostatic hypertrophy with temporal effect.
